Display options
Share it on

Int J Reprod Biomed. 2020 Sep 20;18(9):747-754. doi: 10.18502/ijrm.v13i9.7669. eCollection 2020 Sep.

Role of the 820 A/G variant in the .

International journal of reproductive biomedicine

Farzaneh Ardeshir, Leila Keshavarz, Fatemeh Asadian, Gohar Omidmokhtarkhanloo, Majid Yavarian

Affiliations

  1. Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran.
  2. Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
  3. Persian Bayan Gene Research and Training Center, Dr. Faghihi's Medical Genetic Center, Siraz, Iran.
  4. Shiraz Nephron-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 33062920 PMCID: PMC7521167 DOI: 10.18502/ijrm.v13i9.7669

Abstract

BACKGROUND: Insulin-like growth factor-2 (

OBJECTIVE: This cross-sectional study aimed to investigate the role of 820A/G variant of the

MATERIALS AND METHODS: In this study, 50 aborted fetuses tissue for the study group and blood samples umbilical-cord from newborns as control group (n = 50) were collected from Shiraz-Iran (2017). The genotyping of the target point in the

RESULTS: Based on the collected data (AA genotype = reference), allele "A" frequency in aborted fetus was 51% and control 68% as well as allele G 49% and 32%, respectively. Moreover, 27 aborted embryos (54%) were heterozygous (A/G) (OR = 3.274, 95% CI = 1.015-10.561, p = 0.04), while 18 cases (36%) in control sample showed heterozygosity. Considering the phenotypic status, the G allele had a dominant effect on the incidence of RSA (p = 0.008, OR = 3.167).

CONCLUSION: Based on the present study, the risk of abortion due to loss of heterozygosity or quantitative decline of the

Copyright © 2020 Ardeshir et al.

Keywords: Gene expression; Genomic imprinting; IGF-2; Spontaneous abortion; Variant

Conflict of interest statement

There is no conflict of interest in this study.

References

  1. J Endocrinol. 2004 Dec;183(3):487-96 - PubMed
  2. Int J Mol Med. 2011 Oct;28(4):481-7 - PubMed
  3. Obstet Gynecol Int. 2010;2010:965905 - PubMed
  4. J Clin Endocrinol Metab. 2003 Oct;88(10):4811-7 - PubMed
  5. Endocr Dev. 2009;14:20-8 - PubMed
  6. Genome Biol. 2011 Mar 21;12(3):106 - PubMed
  7. Hum Mol Genet. 2004 Apr 1;13(7):715-25 - PubMed
  8. Genet Epigenet. 2013 Mar 10;5:17-22 - PubMed
  9. Curr Opin Obstet Gynecol. 2012 Aug;24(4):229-34 - PubMed
  10. Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8309-14 - PubMed
  11. Lab Invest. 1998 May;78(5):641-2 - PubMed
  12. Am J Med Genet A. 2009 Nov;149A(11):2415-23 - PubMed
  13. Cancer Res. 2002 Nov 15;62(22):6442-6 - PubMed
  14. Cold Spring Harb Symp Quant Biol. 1985;50:45-50 - PubMed
  15. Mol Reprod Dev. 1997 Jun;47(2):134-9 - PubMed
  16. J Clin Endocrinol Metab. 2001 Aug;86(8):3665-74 - PubMed
  17. Am J Reprod Immunol. 2008 Aug;60(2):111-7 - PubMed
  18. Mol Cell Biol. 1996 Jun;16(6):2802-13 - PubMed
  19. Hum Mol Genet. 2003 Mar 1;12(5):535-49 - PubMed
  20. J Cell Physiol. 2002 Sep;192(3):245-58 - PubMed
  21. J Physiol. 2003 Feb 15;547(Pt 1):35-44 - PubMed
  22. Am J Obstet Gynecol. 1984 Jan 15;148(2):140-6 - PubMed
  23. Chang Gung Med J. 2006 Jan-Feb;29(1):25-36 - PubMed
  24. J Clin Endocrinol Metab. 2007 Aug;92(8):3148-54 - PubMed
  25. Br J Cancer. 2000 Jan;82(2):385-91 - PubMed
  26. Diabetes. 2003 Jun;52(6):1403-8 - PubMed
  27. Acta Obstet Gynecol Scand. 2010 Mar;89(3):360-6 - PubMed
  28. Nat Genet. 1997 Feb;15(2):122-3 - PubMed
  29. J Biol Chem. 1996 May 10;271(19):11330-8 - PubMed
  30. Am J Reprod Immunol. 2012 Apr;67(4):334-40 - PubMed

Publication Types